CV: General Diabetes Flashcards
What are the short acting insulin analogues?
Aspart
GLULISINE
Lispro
Soluble human/bovine/porcine insulin.
What are the long acting insulin analogues?
Determir Glargine Degludec Protamine Zinc Insulin Zinc
Aspart: short or long acting?
Short
Determir: short or long acting?
Long
Glargine: short or long acting?
Long
Lispro: short or long acting?
Short
Glulisine: short or long acting?
Short
Degludec: short or long acting?
Long
Glargine: once or twice daily?
Once
Degludec: once or twice daily?
Once
Determir: once or twice daily?
either
A long-acting recombinant human insulin analogue:
Actrapid Humalog Mix 25 Hypurin porcine isophane Insultard Lantus Victoza Novomix 30 Novorapid
Actrapid: Fast-acting Human insulin produced by recombinant DNA technology in Saccharomyces cerevisiae. Most appropriate to use in diabetic emergency and at time of surgery.
Humalog Mix 25: Insulin lispro (recombinant DNA from E.coli) + 75% insulin lispro protamine.
Hypurin porcine: pig insulin
Insulatard: human insulin with a gradual onset and long duration of action: recombinant DNA therapy in Saccharoymces cervisiae.
Lantus: long acting recombinant insulin analogue: glargine.
Victoza: Liraglutide, GLP-1 agonist, weight loss.
Novomix 30: mixture or fast acting insulin aspart and protamine insulin aspart.
Novorapid: just insulin aspart, so rapid-acting/short duration of action.
The most appropriate to use in a diabetic emergency and at the time of surgery:
Actrapid Humalog Mix 25 Hypurin porcine isophane Insultard Lantus Victoza Novomix 30 Novorapid
Actrapid: Fast-acting Human insulin produced by recombinant DNA technology in Saccharomyces cerevisiae. Most appropriate to use in diabetic emergency and at time of surgery.
Humalog Mix 25: Insulin lispro (recombinant DNA from E.coli) + 75% insulin lispro protamine.
Hypurin porcine: pig insulin
Insulatard: human insulin with a gradual onset and long duration of action: recombinant DNA therapy in Saccharoymces cervisiae.
Lantus: long acting recombinant insulin analogue: glargine.
Victoza: Liraglutide, GLP-1 agonist, weight loss.
Novomix 30: mixture or fast acting insulin aspart and protamine insulin aspart.
Novorapid: just insulin aspart, so rapid-acting/short duration of action.
Associated with the prevention of weight gain and the possible promotion of weight loss:
Actrapid Humalog Mix 25 Hypurin porcine isophane Insultard Lantus Victoza Novomix 30 Novorapid
Actrapid: Fast-acting Human insulin produced by recombinant DNA technology in Saccharomyces cerevisiae. Most appropriate to use in diabetic emergency and at time of surgery.
Humalog Mix 25: Insulin lispro (recombinant DNA from E.coli) + 75% insulin lispro protamine.
Hypurin porcine: pig insulin
Insulatard: human insulin with a gradual onset and long duration of action: recombinant DNA therapy in Saccharoymces cervisiae.
Lantus: long acting recombinant insulin analogue: glargine.
Victoza: Liraglutide, GLP-1 agonist, weight loss.
Novomix 30: mixture or fast acting insulin aspart and protamine insulin aspart.
Novorapid: just insulin aspart, so rapid-acting/short duration of action.
Stimulates insulin secretion from pancreatic beta cells with a short duration of action:
Empaglifozin Isophane insulin Metformin Nateglinide Once daily long-acting insulin analogue Pioglitazone Rapid-acting insulin analogue Twice daily premixed insulin
Empaglifozin: SGLT-2, blood pressure monitoring is recommended in patients also on anti-hypertensives
Isophane insulin: NICE recommended insulin of choice for insulin initiation in type 2 diabetics.
Metformin: decreased hepatic glucose production, decreased intestinal absorption of glucose, improved insulin sensitivity by increasing peripheral glucose uptake and utilisation.
Nateglinide: stimulates insulin secretion from pancreatic beta cells with a short duration of action.
Once-daily long-acting insulin analogue.
Pioglitazone: not suitable for people with or at high risk of HF: fluid retention.
Rapid-acting insulin analogue:
Twice daily premixed insulin: NICE recommended second-choice insulin if a basal-bolus regimen is not acceptable for a person with type 1 diabetes.